| CFIHX | RCEEX | CFIHX / RCEEX | |
| Total Expense Ratio | 0.26 | 1.06 | 25% |
| Annual Report Gross Expense Ratio | 0.26 | 1.06 | 25% |
| Fund Existence | 10 years | 12 years | - |
| Gain YTD | 8.786 | 8.189 | 107% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 131B | 131B | 100% |
| Annual Yield % from dividends | 2.96 | 2.24 | 132% |
| Returns for 1 year | 7.10 | 6.23 | 114% |
| Returns for 3 years | 43.57 | 40.14 | 109% |
| Returns for 5 years | 40.67 | 35.96 | 113% |
| Returns for 10 years | N/A | 64.93 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBDIX | 193.46 | N/A | N/A |
| Franklin Biotechnology Discovery A | |||
| VITPX | 125.08 | N/A | N/A |
| Vanguard MStar Inst Ttl StkMktIdxInstlPl | |||
| JFCIX | 37.80 | N/A | N/A |
| JHancock Fundamental All Cap Core I | |||
| GSNPX | 25.54 | N/A | N/A |
| Goldman Sachs International Eq Inc P | |||
| SQBFX | 16.25 | N/A | N/A |
| X-Square Balanced Fund, LLC A | |||